Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2001, p. 6808-6819, Vol. 21, No. 20
Cell Biology and Metabolism Branch, National
Institute of Child Health and Human Development, National
Institutes of Health, Bethesda, Maryland 20892
Received 7 June 2001/Returned for modification 2 July 2001/Accepted 12 July 2001
In vitro, the TAFII60 component of the TFIID complex
contributes to RNA polymerase II transcription initiation by serving as
a coactivator that interacts with specific activator proteins and
possibly as a promoter selectivity factor that interacts with the
downstream promoter element. In vivo roles for TAFII60 in metazoan transcription are not as clear. Here we have investigated the
developmental and transcriptional requirements for TAFII60 by analyzing four independent Drosophila
melanogaster
TAFII60 mutants.
Loss-of-function mutations in Drosophila
TAFII60 result in lethality, indicating
that TAFII60 provides a nonredundant function in vivo.
Molecular analysis of TAFII60
alleles revealed that essential TAFII60 functions are
provided by two evolutionarily conserved regions located in the
N-terminal half of the protein. TAFII60 is required at all
stages of Drosophila development, in both germ cells and
somatic cells. Expression of TAFII60 from a transgene
rescued the lethality of TAFII60 mutants and exposed requirements for TAFII60 during
imaginal development, spermatogenesis, and oogenesis. Phenotypes of
rescued TAFII60 mutant flies
implicate TAFII60 in transcriptional mechanisms that regulate cell growth and cell fate specification and suggest that TAFII60 is a limiting component of the machinery that
regulates the transcription of dosage-sensitive genes. Finally,
TAFII60 plays roles in developmental regulation of gene
expression that are distinct from those of other TAFII
proteins.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.20.6808-6819.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Developmental and Transcriptional Consequences of
Mutations in Drosophila
TAFII60
and
*
Corresponding author. Present address: Department of
Pharmacology, University of Wisconsin Medical School, 1300 University Ave., Madison, WI 53706. Phone: (608) 262-6648. Fax: (608)
262-1257. E-mail: dawassarman{at}facstaff.wisc.edu.
Present address: Department of Biological Science and Technology,
Science University of Tokyo, Noda, Chiba 278-8510, Japan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»